919 results on '"Yin, Yongmei"'
Search Results
152. Chinese expert consensus on coronavirus disease 2019 vaccination for breast cancer patients
153. Determination of Amaranth in Beverage by Indirect Competitive Enzyme-linked Immunosorbent Assay (ELISA) Based on Anti-amaranth Monoclonal Antibody
154. Electrochemical method to characterize multidrug resistance
155. Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
156. Electrochemical assay of the relationship between the inhibition of phosphatidylinositol 3-kinase pathway and estrogen receptor expression in breast cancer
157. Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability
158. Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study
159. A Prospective, Single-Arm, Phase II Trial of Apatinib Combined With Nab-Paclitaxel and Carboplatin for The Neoadjuvant Treatment of Triple-Negative Breast Cancer
160. High Rate of Epidermal Growth Factor Receptor-Mutated Primary Lung Cancer in Patients with Primary Breast Cancer
161. Rapid Naked-Eye Tracking of On-Cell Phenotype Based on Dual-Aptamer-Weaved Cascade Assembly of Nanostructures
162. Safety profile of poly (ADP-ribose) polymerase (PARP) inhibitors in cancer: a network meta-analysis of randomized controlled trials
163. Co-assembly of Peptides and Carbon Nanodots: Sensitive Analysis of Transglutaminase 2
164. Risk Signature of Cancer-Associated Fibroblast–Secreted Cytokines Associates With Clinical Outcomes of Breast Cancer
165. MO32-4 A real-world multicentre retrospective study of low-dose apatinib for HER2-negative metastatic breast cancer
166. P16-3 Maintenance therapy in HER2 and hormone receptor-positive breast cancer
167. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer
168. A case of intimal sarcoma of the pulmonary artery successfully treated with chemotherapy
169. Subgroup analysis by Ki-67 and baseline CgA of the randomized, placebo-controlled phase 3 study of surufatinib in advanced well-differentiated pancreatic neuroendocrine tumors (SANET-p).
170. A phase Ib study of proxalutamide (GT0918) in women with androgen receptor-positive metastatic breast cancer.
171. A phase Ib study of the PI3Kδ inhibitor linperlisib in patients with advanced solid tumors.
172. A phase 2 study of pamiparib in the treatment of patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutation.
173. DNA-Based pH Nanosensor with Adjustable FRET Responses to Track Lysosomes and pH Fluctuations
174. Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study
175. Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer
176. Cyclin-dependent kinase 4 and 6 inhibitors at the crossroads: the combinational therapeutic strategies in breast cancer—a narrative review
177. Comparative SPR study on the effect of nanomaterials on the biological activity of adsorbed proteins
178. The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study
179. Functionalization of platinum nanoparticles for electrochemical detection of nitrite
180. Synthesis of Diboronic Acid-Based Fluorescent Probes for the Sensitive Detection of Glucose in Aqueous Media and Biological Matrices
181. Attitudes and Practices of Immune Checkpoint Inhibitors in Chinese Patients With Cancer: A National Cross-Sectional Survey
182. Abstract PS13-25: Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study
183. Abstract PS13-01: Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer
184. Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China
185. Chinese expert consensus statement on the clinical diagnosis and treatment of breast cancer bone metastasis and bone related disease
186. A simple method to assay tumor cells based on target-initiated steric hindrance
187. Additional file 1 of Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population
188. Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers
189. Comparative study of gemcitabine plus cisplatin and gemcitabine plus fluorouracil in the treatment of advanced pancreatic cancer
190. Detection of colorectal cancer-derived exosomes based on covalent organic frameworks
191. Effect of an Artificial Intelligence Clinical Decision Support System on Treatment Decisions for Complex Breast Cancer
192. Pamiparib dose escalation in Chinese patients with non‐mucinous high‐grade ovarian cancer or advanced triple‐negative breast cancer
193. Guidelines of Chinese Society of Clinical Oncology (CSCO) on Diagnosis and Treatment of Breast Cancer (2020 version)
194. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor
195. Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer
196. MKL1 Mediates TGF-β Induced RhoJ Transcription to Promote Breast Cancer Cell Migration and Invasion
197. A Case of Kikuchi-Fujimoto Disease in a 7-Year-Old African American Patient: A Case Report and Review of Literature
198. Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19
199. Renal safety and efficacy of angiotensin receptor‐neprilysin inhibitor: A meta‐analysis of randomized controlled trials
200. Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.